Thursday, January 10, 2013- Look for massive home health consolidation in 2013, expert saysat bizjournals.com (Thu, Jan 10)
- 4 Healthcare Stock Stories for Investors to Take Dailyat Wall St. Cheat Sheet (Thu, Jan 10)
- Should You Invest Like Sherlock Holmes?at Motley Fool (Thu, Jan 10)
- CPRIT Foundation releases donor listat bizjournals.com (Thu, Jan 10)
- Drug companies forge partnerships with top schoolsAP (Thu, Jan 10)
- Pfizer May Push $5 Billion Breast Cancer Hope for Rulingat Bloomberg (Thu, Jan 10)
- The Dow Gets a Booster Shot From Big Pharmaat Motley Fool (Thu, Jan 10)
- Cheating and the Record Booksat Motley Fool (Thu, Jan 10)
- Pfizer Hopes For Expedited Review and 3 Dow Movers Sparking Chatterat Wall St. Cheat Sheet (Thu, Jan 10)
- Correction: Repligen-Pfizer storyAP (Thu, Jan 10)
- What's on the Way for Antares Pharmaat Motley Fool (Thu, Jan 10)
- The Most Neglected Big Biotechat Motley Fool (Thu, Jan 10)
Wednesday, January 9, 2013- Glaxo Says No Plan for Viiv Spinoff ‘at the Moment’at Bloomberg (Wed, Jan 9)
- Should Any Big Pharma Buy Bausch & Lomb?at Motley Fool (Wed, Jan 9)
- JPMorgan Healthcare Conference Highlights: Bristol-Myers Squibbat Motley Fool (Wed, Jan 9)
- Durata Therapeutics: Low Floater With Near-Term Phase III Catalystat Seeking Alpha (Wed, Jan 9)
- Pfizer Takes Interest In Halozyme's Biologics Platformat Seeking Alpha (Wed, Jan 9)
- This Biotech Will Go Even Higherat Motley Fool (Wed, Jan 9)
- Biotech's a Buy, but Hold Off on HMOs: Fund Managerat CNBC (Wed, Jan 9)
- Catalyst-Filled 2013 for OnyxZacks (Wed, Jan 9)
- JPMorgan Healthcare Conference Highlights: Regeneron Pharmaceuticalsat Motley Fool (Wed, Jan 9)
- China Slashing Prices of Hundreds of Drugsat Motley Fool (Wed, Jan 9)
- The Healthcare Dogs of the Dowat Motley Fool (Wed, Jan 9)
- Will AbbVie's Drug Pipeline Cloud Its Growth Prospects?at Motley Fool (Wed, Jan 9)
- PennyMac Trades Cancelled and 4 Stocks Enjoying 52-Week Highsat Wall St. Cheat Sheet (Wed, Jan 9)
Add PFE News to My Yahoo!  | |
|